Literature DB >> 19686524

A comparison of drug overdose deaths involving methadone and other opioid analgesics in West Virginia.

Leonard J Paulozzi1, Joseph E Logan, Aron J Hall, Edna McKinstry, James A Kaplan, Alexander E Crosby.   

Abstract

AIMS: To describe all people dying from unintentional overdoses of methadone or other opioid analgesics (OOA) in West Virginia in 2006.
DESIGN: We analyzed medical examiner data supplemented by data from the state prescription drug monitoring program. We compared people whose deaths involved methadone with those whose deaths involved OOA.
FINDINGS: The methadone group included 87 decedents, and the OOA group included 163 decedents. Most were male. Decedents in the methadone group were significantly younger than those in the OOA group: more than a quarter were 18-24 years of age. For both groups, approximately 50% had a history of pain, and 80% had a history of substance abuse. There was no intergroup difference in the prevalence of benzodiazepines at post-mortem. Methadone was significantly less likely to have ever been prescribed than OOA. Among those with prescriptions, the proportion prescribed within 30 days of death was significantly greater for methadone than for hydrocodone, but not for oxycodone. Ten (11.5%) of the methadone decedents were enrolled in an opiate treatment program (OTP) at the time of death.
CONCLUSIONS: The high prevalence of a substance abuse history and lack of prescriptions suggest that most of the deaths in both groups are related to substance abuse. There was no indication of a harmful effect from methadone's metabolic interaction with benzodiazepines, but provider or patient unfamiliarity with methadone may have been a risk factor. Prescribing methadone, especially to young males, requires extra care. Providers, OTPs and coroners/medical examiners should use state prescription drug monitoring programs to monitor the use of controlled substances by their patients.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19686524     DOI: 10.1111/j.1360-0443.2009.02650.x

Source DB:  PubMed          Journal:  Addiction        ISSN: 0965-2140            Impact factor:   6.526


  33 in total

Review 1.  Update in addiction medicine for the generalist.

Authors:  Adam J Gordon; Hillary V Kunins; Darius A Rastegar; Jeanette M Tetrault; Alexander Y Walley
Journal:  J Gen Intern Med       Date:  2010-08-10       Impact factor: 5.128

2.  ACMT Position Statement: The Use of Methadone as an Analgesic.

Authors: 
Journal:  J Med Toxicol       Date:  2016-06

3.  Multiple Determinants of Specific Modes of Prescription Opioid Diversion.

Authors:  Theodore J Cicero; Steven P Kurtz; Hilary L Surratt; Gladys E Ibanez; Matthew S Ellis; Maria A Levi-Minzi; James A Inciardi
Journal:  J Drug Issues       Date:  2011

Review 4.  Opioids and Chronic Pain: Where Is the Balance?

Authors:  Mellar P Davis; Zankhana Mehta
Journal:  Curr Oncol Rep       Date:  2016-12       Impact factor: 5.075

Review 5.  Determinants of increased opioid-related mortality in the United States and Canada, 1990-2013: a systematic review.

Authors:  Nicholas B King; Veronique Fraser; Constantina Boikos; Robin Richardson; Sam Harper
Journal:  Am J Public Health       Date:  2014-06-12       Impact factor: 9.308

6.  An update on oxycodone: lessons for death investigators in Australia.

Authors:  Jennifer L Pilgrim; Sabrina Putrianita Yafistham; Sanjeev Gaya; Eva Saar; Olaf H Drummer
Journal:  Forensic Sci Med Pathol       Date:  2014-11-18       Impact factor: 2.007

7.  Additive Effects of Cointoxicants in Single-Opioid Induced Deaths.

Authors:  Marcella H Sorg; D Leann Long; Marie A Abate; James A Kaplan; James C Kraner; Margaret S Greenwald; Thomas A Andrew; Steven L Shapiro; Jamie A Wren
Journal:  Acad Forensic Pathol       Date:  2016-09

8.  Individual and network factors associated with prevalent hepatitis C infection among rural Appalachian injection drug users.

Authors:  Jennifer R Havens; Michelle R Lofwall; Simon D W Frost; Carrie B Oser; Carl G Leukefeld; Richard A Crosby
Journal:  Am J Public Health       Date:  2012-11-15       Impact factor: 9.308

Review 9.  An overview of the patterns of prescription opioid use, costs and related harms in Australia.

Authors:  Bianca Blanch; Sallie-Anne Pearson; Paul S Haber
Journal:  Br J Clin Pharmacol       Date:  2014-11       Impact factor: 4.335

10.  Prescription opioid mortality trends in New York City, 1990-2006: examining the emergence of an epidemic.

Authors:  Magdalena Cerdá; Yusuf Ransome; Katherine M Keyes; Karestan C Koenen; Melissa Tracy; Kenneth J Tardiff; David Vlahov; Sandro Galea
Journal:  Drug Alcohol Depend       Date:  2013-01-26       Impact factor: 4.492

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.